FDA on Metformin: OK in Some Patients with Reduced Kidney Function
FDA is requiring a class labeling change that will allow many more diabetes patients to benefit from metformin.
Diabetes Review: The 2 New Insulins on the Block
Got a minute? Check out this concise review of the facts about long-acting insulin formulations Toujeo and Tresiba.
Alternate-Day Statin Therapy
Every-other-day dosing, especially of statins with longer half-lives is shown to preserve lipid-lowering benefits.
Statin-Related Myopathies: Identification and Management
Barriers to the use of statins-the most potent medicine currently available in the fight against atherosclerotic heart disease-are both real and perceived.
The Great Beta-Blocker Debate: The Pros and Cons
Newly diagnosed hypertension in a patient whose blood pressure is 152/94 mm Hg. What agents will you consider for this patient? Beta-blockers? Think again.
Chlorthalidone for Hypertension: Time to Resuscitate an Old, Tried-and-True Agent?
Some say chlorthalidone is superior to hydrochlorothiazide and should be used as first-line therapy in hypertension. A compelling case can be made for resurrecting this venerable drug.
